Screener
Aclaris Therapeutics ACRS Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's gross margin?
- Aclaris Therapeutics (ACRS) reported gross margin of 79.5% in Q2 2026.
- How has Aclaris Therapeutics's gross margin changed year-over-year?
- Aclaris Therapeutics's gross margin decreased by 7.3% year-over-year, from 85.8% to 79.5%.
- What is the long-term trend for Aclaris Therapeutics's gross margin?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's gross margin has grown at a 28.6% compound annual growth rate (CAGR), from 20.8% to 73.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Aclaris Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude